BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 32283322)

  • 1. Foxp3
    Mitchell J; Kelly J; Kvedaraite E; von Bahr Greenwood T; Henter JI; Pellicci DG; Berzins SP; Kannourakis G
    Clin Immunol; 2020 Jun; 215():108418. PubMed ID: 32283322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A potentially important role for T cells and regulatory T cells in Langerhans cell histiocytosis.
    Mitchell JM; Berzins SP; Kannourakis G
    Clin Immunol; 2018 Sep; 194():19-25. PubMed ID: 29928999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical characterization of immune cell infiltration in paediatric and adult Langerhans cell histiocytosis.
    Paredes SEY; Almeida LY; Trevisan GL; Polanco XBJ; Silveira HA; Vilela Silva E; Segato RAB; da Silva LAB; Chahud F; León JE
    Scand J Immunol; 2020 Dec; 92(6):e12950. PubMed ID: 32738155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activated Conventional T-Cells Are Present in Langerhans Cell Histiocytosis Lesions Despite the Presence of Immune Suppressive Cytokines.
    Quispel WT; Stegehuis-Kamp JA; Santos SJ; Egeler RM; van Halteren AG
    J Interferon Cytokine Res; 2015 Oct; 35(10):831-9. PubMed ID: 26381039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Langerhans cell histiocytosis in Chinese adults: absence of BRAF mutations and increased FOXP3(+) regulatory T cells.
    Tong C; Jia X; Jia Y; He Y
    Int J Clin Exp Pathol; 2014; 7(6):3166-73. PubMed ID: 25031736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expansion of regulatory T cells in patients with Langerhans cell histiocytosis.
    Senechal B; Elain G; Jeziorski E; Grondin V; Patey-Mariaud de Serre N; Jaubert F; Beldjord K; Lellouch A; Glorion C; Zerah M; Mary P; Barkaoui M; Emile JF; Boccon-Gibod L; Josset P; Debré M; Fischer A; Donadieu J; Geissmann F
    PLoS Med; 2007 Aug; 4(8):e253. PubMed ID: 17696642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell-specific gene expression in Langerhans cell histiocytosis lesions reveals a distinct profile compared with epidermal Langerhans cells.
    Allen CE; Li L; Peters TL; Leung HC; Yu A; Man TK; Gurusiddappa S; Phillips MT; Hicks MJ; Gaikwad A; Merad M; McClain KL
    J Immunol; 2010 Apr; 184(8):4557-67. PubMed ID: 20220088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morphoproteomics provides support for TGF-β pathway signaling in the osteoclastogenesis and immune dysregulation of osteolytic Langerhans cell histiocytosis.
    Alexandrescu S; Tatevian N; Czerniak BA; Covinsky MH; Burns NK; Brown RE
    Int J Clin Exp Pathol; 2012; 5(6):503-11. PubMed ID: 22949932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma Signaling Factors in Patients With Langerhans Cell Histiocytosis (LCH) Correlate With Relative Frequencies of LCH Cells and T Cells Within Lesions.
    Mitchell J; Kvedaraite E; von Bahr Greenwood T; Lourda M; Henter JI; Berzins SP; Kannourakis G
    Front Pediatr; 2022; 10():872859. PubMed ID: 35844751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The presence of cytokines in Langerhans' cell histiocytosis.
    de Graaf JH; Tamminga RY; Dam-Meiring A; Kamps WA; Timens W
    J Pathol; 1996 Dec; 180(4):400-6. PubMed ID: 9014861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential In situ cytokine profiles of Langerhans-like cells and T cells in Langerhans cell histiocytosis: abundant expression of cytokines relevant to disease and treatment.
    Egeler RM; Favara BE; van Meurs M; Laman JD; Claassen E
    Blood; 1999 Dec; 94(12):4195-201. PubMed ID: 10590064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apparent Lack of
    Kemps PG; Zondag TC; Steenwijk EC; Andriessen Q; Borst J; Vloemans S; Roelen DL; Voortman LM; Verdijk RM; van Noesel CJM; Cleven AHG; Hawkins C; Lang V; de Ru AH; Janssen GMC; Haasnoot GW; Franken KLMC; van Eijk R; Solleveld-Westerink N; van Wezel T; Egeler RM; Beishuizen A; van Laar JAM; Abla O; van den Bos C; van Veelen PA; van Halteren AGS
    Front Immunol; 2019; 10():3045. PubMed ID: 31998317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leishmania donovani mediated higher expression of CCL4 induces differential accumulation of CD4
    Kumari S; Shivam P; Kumar S; Jamal F; Singh MK; Bimal S; Narayan S; Pandey K; Das VNR; Das P; Singh SK
    Cytokine; 2018 Oct; 110():306-315. PubMed ID: 29807685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-17 facilitates the immune suppressor capacity of high-grade glioma-derived CD4 (+) CD25 (+) Foxp3 (+) T cells via releasing transforming growth factor beta.
    Liang H; Yi L; Wang X; Zhou C; Xu L
    Scand J Immunol; 2014 Aug; 80(2):144-50. PubMed ID: 24813240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neonatal and early infantile cutaneous langerhans cell histiocytosis: comparison of self-regressive and non-self-regressive forms.
    Battistella M; Fraitag S; Teillac DH; Brousse N; de Prost Y; Bodemer C
    Arch Dermatol; 2010 Feb; 146(2):149-56. PubMed ID: 20157025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigen, in the presence of TGF-beta, induces up-regulation of FoxP3gfp+ in CD4+ TCR transgenic T cells that mediate linked suppression of CD8+ T cell responses.
    Kapp JA; Honjo K; Kapp LM; Goldsmith K; Bucy RP
    J Immunol; 2007 Aug; 179(4):2105-14. PubMed ID: 17675469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methionine enkephalin (MENK) inhibits tumor growth through regulating CD4+Foxp3+ regulatory T cells (Tregs) in mice.
    Li X; Meng Y; Plotnikoff NP; Youkilis G; Griffin N; Wang E; Lu C; Shan F
    Cancer Biol Ther; 2015; 16(3):450-9. PubMed ID: 25701137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polyclonal T-cells express CD1a in Langerhans cell histiocytosis (LCH) lesions.
    West JA; Olsen SL; Mitchell JM; Priddle RE; Luke JM; Akefeldt SO; Henter JI; Turville C; Kannourakis G
    PLoS One; 2014; 9(10):e109586. PubMed ID: 25343480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Langerhans cell histiocytosis: a cytokine/chemokine-mediated disorder?
    Garabedian L; Struyf S; Opdenakker G; Sozzani S; Van Damme J; Laureys G
    Eur Cytokine Netw; 2011 Sep; 22(3):148-53. PubMed ID: 22001902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abundant expression of CD40 and CD40-ligand (CD154) in paediatric Langerhans cell histiocytosis lesions.
    Egeler RM; Favara BE; Laman JD; Claassen E
    Eur J Cancer; 2000 Oct; 36(16):2105-10. PubMed ID: 11044648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.